Davenport & Co’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,577
Closed -$237K 1217
2025
Q1
$237K Sell
1,577
-14,469
-90% -$2.43M ﹤0.01% 1084
2024
Q4
$2.94M Sell
16,046
-701
-4% -$135K 0.02% 397
2024
Q3
$3.32M Sell
16,747
-1,742
-9% -$362K 0.02% 359
2024
Q2
$3.83M Buy
18,489
+5,582
+43% +$1.26M 0.02% 333
2024
Q1
$3.48M Buy
12,907
+4,925
+62% +$1.18M 0.02% 350
2023
Q4
$1.9M Buy
+7,982
New +$1.57M 0.01% 427
2022
Q3
Sell
-939
Closed -$201K 998
2022
Q2
$201K Buy
939
+85
+10% +$20.8K ﹤0.01% 917
2022
Q1
$243K Sell
854
-112
-12% -$34.5K ﹤0.01% 943
2021
Q4
$364K Sell
966
-530
-35% -$206K ﹤0.01% 844
2021
Q3
$617K Buy
1,496
+793
+113% +$329K ﹤0.01% 669
2021
Q2
$260K Buy
+703
New +$235K ﹤0.01% 839

Other funds holding CRL